Giuseppe Guido Maria Scarlata
Overview
Explore the profile of Giuseppe Guido Maria Scarlata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Scarlata G, Colaci C, Scarcella M, Dallio M, Federico A, Boccuto L, et al.
Diseases
. 2024 Apr;
12(4).
PMID: 38667527
Alcoholic liver disease (ALD) is a major cause of chronic liver disease. This term covers a broad spectrum of liver lesions, from simple steatosis to alcoholic hepatitis and cirrhosis. The...
12.
Spagnuolo R, Scarlata G, Paravati M, Abenavoli L, Luzza F
Antibiotics (Basel)
. 2024 Apr;
13(4).
PMID: 38667033
() infection is a prevalent global health issue, associated with several gastrointestinal disorders, including gastritis, peptic ulcers, and gastric cancer. The landscape of treatment has evolved over the years, with...
13.
Boccabella L, Palma E, Abenavoli L, Scarlata G, Boni M, Ianiro G, et al.
Antibiotics (Basel)
. 2024 Mar;
13(3).
PMID: 38534668
Background And Aim: Antimicrobial resistance (AMR) is a chronic issue of our Westernized society, mainly because of the uncontrolled and improper use of antimicrobials. The coronavirus disease 2019 (COVID-19) pandemic...
14.
Cetkovic N, Scarlata G, Abenavoli L
Nutrients
. 2024 Feb;
16(3).
PMID: 38337701
We read with great interest the recent article by Meneghini et al. on the assessment of the effects of different alimentary regimens, included Mediterranean diet (MD), on polycystic ovary syndrome...
15.
Abenavoli L, Spagnuolo R, Scarlata G, Scarpellini E, Boccuto L, Luzza F
Medicina (Kaunas)
. 2023 Nov;
59(11).
PMID: 38003983
: Inflammatory bowel disease (IBD) is a condition characterized by chronic intestinal inflammation. We can identify two major forms: Crohn's disease (CD) and ulcerative colitis (UC). One of the extraintestinal...
16.
Quirino A, Cicino C, Scarlata G, Marascio N, Di Gennaro G, Matera G, et al.
Antibiotics (Basel)
. 2023 Oct;
12(10).
PMID: 37887226
Combating antimicrobial resistance (AMR) requires comprehensive efforts, such as screening to identify patients colonized by multidrug-resistant microorganisms (MDROs). The primary purpose of this study was to estimate the AMR pattern...
17.
Abenavoli L, Aquila I, Sacco M, Scarlata G, Procopio A, Boccuto L, et al.
Diseases
. 2023 Oct;
11(4).
PMID: 37873785
Methods: Ten patients suffering from severe COVID-19 disease who died between January 2020 and December 2021 were included in the present analysis. These subjects underwent a post mortem examination with...
18.
Abenavoli L, Scarpellini E, Paravati M, Scarlata G, Boccuto L, Tilocca B, et al.
Nutrients
. 2023 Aug;
15(16).
PMID: 37630759
Critically ill patients have a hyper-inflammatory response against various offending injuries that can result in tissue damage, organ failure, and fatal prognosis. The origin of this detrimental, uncontrolled inflammatory cascade...
19.
Abenavoli L, Montori M, Svegliati Baroni G, Argenziano M, Giorgi F, Scarlata G, et al.
Medicina (Kaunas)
. 2023 Aug;
59(8).
PMID: 37629716
Hepatocellular carcinoma (HCC) is the leading cause of liver cancer worldwide and has a high mortality rate. Its incidence has increased due to metabolic-associated liver disease (MAFLD) epidemics. Liver transplantation...
20.
Abenavoli L, Scarlata G, Paravati M, Boccuto L, Luzza F, Scarpellini E
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509432
Liver transplantation (LT) is the treatment of choice for patients with cirrhosis, decompensated disease, acute liver failure, and hepatocellular carcinoma (HCC). In 3-25% of cases, an alarming problem is acute...